MedLife, the largest private medical services network in Romania, announces that it has reached a stock market capitalization of EUR 1 billion on the Bucharest Stock Exchange (BVB), thus becoming the most valuable company in the healthcare sector in Romania.
“Reaching the EUR 1 billion capitalization threshold is an important validation for us and proof that the MedLife model remains solid and relevant, regardless of the context. It is the result of consistent work over three decades and the trust that our investors, partners and colleagues have placed in us. We thank everyone for being part of this evolution. We are going through a complex period, with economic, social and geopolitical pressures. However, we believe that, with the implementation of the latest public policies at national level, Romania has the chance to move in the right direction. As far as we are concerned, we remain focused on investments in innovation and medical research: genomics, artificial intelligence – especially in imaging and laboratory, the development of prevention programs and the continuation of personalized medicine projects,” said Mihai Marcu, President and CEO of MedLife Group.
Main financial achievements in the 9 years since the listing of BVB
- Total assets: from RON 466 million in 2016 to RON 3.02 billion in 2024, +548% compared to 2016
- Turnover: from RON 502 million in 2016 to RON 2.72 billion in 2024, +441% or 5.4 times compared to the time of listing
- EBITDA: from RON 70 million pro-forma in 2016 to RON 416 million pro-forma in 2024, +494% or 5.9 times compared to the time of listing
- Flagship performance: the first private operator in Romania to exceed the threshold of EUR 500 million pro-forma turnover
